Atlas Trials

Safety Study of COVID19 Vaccine on the Market

Clinical trial NCT05890521 · UNKNOWN

Trial details

NCT number
NCT05890521
Sponsor
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19
Start date
2022-04-02
Primary completion
2022-06-16
Enrollment
100000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.